Tip 2 Diyabette Koroner Arter Hastalığı Varlığı Serebrovasküler Hastalık İçin Bir Risk Faktörü müdür?

Amaç: Bu çalışmada, koroner arter hastalığı olan tip 2 diyabetik hastalar ile nefropatisi olan tip2 diyabetik hastaları ana karotis intima–media kalınlığı açısından karşılaştırmak amaçlanmıştır.Gereç ve Yöntemler: Çalışmaya koroner arter hastalığı olan tip 2 diyabetik hastalar (n=36) ve koronerarter hastalığı olmayan, nefropati ile komplike tip 2 diyabetik hastalar (n=31) alındı. Sağ vesol ana karotis arter intima–media kalınlığı B-mod ultrasonografi ile değerlendirildi. Hastalardakardiyovasküler hastalık açısından diğer geleneksel risk faktörleri de değerlendirildi.Bulgular: Koroner arter hastalığının eşlik ettiği diyabet hastalarında hem sağ hem de sol anakarotis arter intima–media kalınlığı, sadece nefropatinin eşlik ettiği diyabet hastalarına göre anlamlıderecede fazla bulundu (sağ ana karotis için 0,99 mm’ye 0,82 mm, sol ana karotis için 1,07mm’ye 0,92 mm; her ikisi için de p0,05).Tartışma ve Sonuç: Koroner arter hastalığı varlığı tip 2 diyabette eşlik eden serebrovaskülerhastalık için önemli bir göstergedir.

Is Presence of Coronary Artery Disease in Type 2 Diabetes a Risk Factor for Cerebrovascular Disease?

Aim: This study aims to compare type 2 diabetic patients with coronary artery disease and type 2 diabetic patients with nephropathy in terms of common carotid artery intima–media thickness. Materials and Methods: The study included type 2 diabetics with coronary artery disease (n=36) and type 2 diabetics without coronary artery disease but with complicating nephropathy (n=31). The right and left common carotid arteries were evaluated in terms of intima–media thickness by using B-mode ultrasonography. Other traditional risk factors for cardiovascular disease were also evaluated. Results: Both right and left common carotid artery intima–media thicknesses were found to be significantly greater for the diabetics with concomitant coronary artery disease than for the diabetics with concomitant nephropathy only (0.99 mm vs 0.82 mm for the right and 1.07 mm vs. 0.92 mm for the left common carotid artery; p0.05 for all). Discussion and Conclusion: Presence of coronary artery disease is an important indicator for concomitant cerebrovascular disease in type 2 diabetics.

PDF

___

Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R ve ark. Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 1990;21:1567–72.
Ludwig M, Kraft K, Rucker W, Huther AM. Diagnosis of very early arteriosclerotic vascular wall changes using duplex sonography. Klin Wochenschr. 1989;67:442– 6.
Yokoyama H, Katakami N, Yamasaki Y. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke. 2006;37:2420–7.
de Zeeuw D, Remuzzi G, Parving HH ve ark. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921–7.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–305.
Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y ve ark. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care. 2000;23:1310–5.
Wagenknecht LE, D’Agostino RB, Haffner S, Savage P, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 1998;21:1812–8.
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893–8.
Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035–8.
Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med. 1997;157(13):1413–8.
Sarnak MJ, Levey AS, Schoolwerth AC vd. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108(17):2154–69.
Hodis HN, Mack WJ, LeBree L ve ark. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262–9.
DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53:1270–87.
Mazzone T. Reducing cardiovascular disease in patients with diabetes mellitus. Curr Opin Cardiol. 2005;20:245– 9.
DeFronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773–95.
Stratton LM, Adler AJ, Neil HA ve ark. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.
Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl. 2):S14– S21.